Blog Posts

Interview #02

7/4/2019

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Singapore)

In the second post of the interview series, our team members, Raja Mukesh Dokala, Senior Manager and Khusnuma Begum, Senior Analyst discussed the current status of RWD in Singapore with Prof Teo Eng Kiong, HoD, Department of Gastroenterology and Chairman, Medical Board, Changi General Hospital, Singapore.

Real world data is essential because it reflects what really happens! It also helps us track how many patients cannot afford it (an expensive therapy) and what percent actually gets successfully treated.

1 Comment

Interview #01

6/5/2019

0 Comments

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Australia)

The use of real-world data (RWD) to supplement randomized clinical trials has been a growing trend recently. Several companies started using RWD to make informed pricing and reimbursement decisions and are also exploring other ways to use RWD in developing their clinical pipeline. At the same time, several countries are deliberating on how to employ real-world evidence (RWE) in their drug approval process.

... Australia or anywhere else the biggest problem now is noise in the data.

0 Comments

Case Study #02

6/3/2019

0 Comments

Key Stakeholder Engagement Strategy for a Point of Care Device Company
(Focus: APAC)

Background: A leading medical device company is planning to launch a Point of Care (PoC) device for detecting infectious disease in Singapore. The company is looking for support with the key clinical stakeholder engagement strategy for their sales team.

0 Comments

HCP Preference Study using Verifothesis Panel #02

5/7/2019

0 Comments

Lab Professionals Preference Study
(Focus: Australia, India, Malaysia and New Zealand)

Authors: K. Begum, S. Kunnath

Last month, we published our findings about panelist preferences towards participation in research studies, from the physicians view point. In continuation, we are now publishing the findings from the perspective of lab professionals.

Objective
For a new reader here is a quick recap of our objective - to learn the preference of our panelists regarding ‘Mode of communication’, ‘Length of interview’, and ‘Method of compensation transfer’. We designed a multiple-choice questionnaire consisting of eight questions and deployed it through our analysts.

0 Comments

HCP Preference Study using Verifothesis Panel #01

4/9/2019

0 Comments

Physician Preference Study (Focus: India, Malaysia, Philippines, Singapore)

Authors: J. R. Philomen, K. Begum

Oncofocus maintains an in-house panel of healthcare professionals by the name of Verifothesis, which gives us access to more than 20,000 healthcare professionals. We decided to use Verifothesis to conduct a short survey to understand how our panelists prefer to participate in research studies. This blog is based on a top-level analysis of the first batch of survey results.

Objective –
Through a questionnaire consisting of eight questions, we aimed to learn the preference of our respondents in three aspects - Mode of communication, Length of interview, and Method of compensation transfer

0 Comments

<<Previous

Forward>>

All work and no blog will make us dull blokes!

Interview #02

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Singapore)

Interview #01

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Australia)

Case Study #02

Key Stakeholder Engagement Strategy for a Point of Care Device Company
(Focus: APAC)

HCP Preference Study using Verifothesis Panel #02

Lab Professionals Preference Study
(Focus: Australia, India, Malaysia and New Zealand)

HCP Preference Study using Verifothesis Panel #01

Physician Preference Study (Focus: India, Malaysia, Philippines, Singapore)

Categories

All work and no blog will make us dull blokes!

Interview #02

Real-World Data and Real-World Evidence: Current status in the APAC region(Focus: Singapore)

Interview #01

Real-World Data and Real-World Evidence: Current status in the APAC region(Focus: Australia)

Case Study #02

Key Stakeholder Engagement Strategy for a Point of Care Device Company ​(Focus: APAC)

HCP Preference Study using Verifothesis Panel #02

Lab Professionals Preference Study ​​(Focus: Australia, India, Malaysia and New Zealand)

HCP Preference Study using Verifothesis Panel #01

Physician Preference Study (Focus: India, Malaysia, Philippines, Singapore)

Categories

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Singapore)

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Australia)

Key Stakeholder Engagement Strategy for a Point of Care Device Company
(Focus: APAC)

Lab Professionals Preference Study
(Focus: Australia, India, Malaysia and New Zealand)